11 Sep 2020
// BUSINESS WIRE
07 May 2019
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/cancer-prevention-pharmaceuticals-cpp-and-mallinckrodt-announce-results-from-pivotal-phase-3-trial-of-cpp-1xsulindac-in-patients-with-familial-adenomatous-polyposis-300844713.html
LOOKING FOR A SUPPLIER?